0001114220-18-000093.txt : 20180816
0001114220-18-000093.hdr.sgml : 20180816
20180816071050
ACCESSION NUMBER: 0001114220-18-000093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180815
FILED AS OF DATE: 20180816
DATE AS OF CHANGE: 20180816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neylan John F.
CENTRAL INDEX KEY: 0001640447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 181022296
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_153441783359781.xml
FORM 4
X0306
4
2018-08-15
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001640447
Neylan John F.
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Medical Officer
Common Stock
2018-08-15
4
S
0
1186
3.04
D
150688
D
Sale of a total of 1,186 shares of common stock was made in order to satisfy Mr. Neylan's income tax withholding obligation upon the vesting of 4,063 shares of restricted stock on August 14, 2018. Mr. Neylan had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 74,581 shares of restricted stock.
/s/ Scott A. Holmes, Attorney-in-Fact
2018-08-16